{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:13:32Z","timestamp":1791026012892,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019704","name":"Konkuk University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HeartRhythm Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.hrcr.2022.12.013","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:10:44Z","timestamp":1671538244000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel trans-2,3-enoyl-CoA reductase\u2013like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-8649","authenticated-orcid":false,"given":"Fatme","family":"Charafeddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-0435","authenticated-orcid":false,"given":"Ziad","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrcr.2022.12.013_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00246-012-0256-1","article-title":"Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia","volume":"33","author":"Faggioni","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrcr.2022.12.013_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.2007.00766.x","article-title":"Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Mohamed","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrcr.2022.12.013_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","article-title":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Pflaumer","year":"2012","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrcr.2022.12.013_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hlc.2019.10.013","article-title":"50 Years of catecholaminergic polymorphic ventricular tachycardia (CPVT) - time to explore the dark side of the moon","volume":"29","author":"Pflaumer","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrcr.2022.12.013_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1540-8167.2007.00913.x","article-title":"A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22","volume":"18","author":"Bhuiyan","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrcr.2022.12.013_bib6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jce.14446","article-title":"Novel variants in TECRL cause recessive inherited CPVT type 3 with severe and variable clinical symptoms","volume":"31","author":"Moscu-Gregor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrcr.2022.12.013_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/europace\/euaa376","article-title":"Life-threatening arrhythmias with autosomal recessive TECRL variants","volume":"23","author":"Webster","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrcr.2022.12.013_bib8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.15252\/emmm.201505719","article-title":"TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT","volume":"8","author":"Devalla","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.hrcr.2022.12.013_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.01.018","article-title":"A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family","volume":"62","author":"Xie","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.hrcr.2022.12.013_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.hrcr.2022.12.013_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patterns, arrhythmic risks, and underlying mechanisms of CASQ2-catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Ng","year":"2020","journal-title":"Circulation"}],"container-title":["HeartRhythm Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221402712200255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221402712200255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:35:19Z","timestamp":1761993319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221402712200255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S221402712200255X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrcr.2022.12.013","relation":{},"ISSN":["2214-0271"],"issn-type":[{"value":"2214-0271","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel trans-2,3-enoyl-CoA reductase\u2013like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3","name":"articletitle","label":"Article Title"},{"value":"HeartRhythm Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrcr.2022.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}